These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 22245293)

  • 1. Histologic inflammatory changes on the prostatic gland due to immunosuppression for kidney transplantation.
    Piovesan AC; Torricelli FC; Antonopoulos IM; Falci R; Kanashiro H; Nahas WC
    Urology; 2012 Mar; 79(3):662-4. PubMed ID: 22245293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Transurethral resection or incision of the prostate in the immediate postoperative follow-up of renal transplantation].
    Védrine N; Nsabimbona B; Soares P; Deteix P; Boiteux JP; Guy L
    Prog Urol; 2009 Dec; 19(11):845-9. PubMed ID: 19945670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A clinical analysis of benign prostatic hyperplasia with chronic prostatitis].
    Wu XJ; Yang LY; Zhang XZ
    Zhonghua Nan Ke Xue; 2008 Jun; 14(6):527-9. PubMed ID: 18649752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inflammatory changes in the obstructed prostate: the correlation between the bacteriological and histological findings].
    Soler Soler JL; Martínez Torres JL; Hidalgo Domínguez Mdel R; Lardelli Claret P; Liébana Ureña J; Zuluaga Gómez A; Saharour G
    Arch Esp Urol; 1999 Sep; 52(7):729-38. PubMed ID: 10540763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of interleukin-8 in expressed prostatic secretion as a reliable biomarker of inflammation in benign prostatic hyperplasia.
    Liu L; Li Q; Han P; Li X; Zeng H; Zhu Y; Wei Q
    Urology; 2009 Aug; 74(2):340-4. PubMed ID: 19464042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transurethral incision/resection of the prostate (TUIP/TURP) in operative treatment of repeated bladder outlet obstruction early after kidney transplantation.
    Mokos I; Kastelan Z; Basić-Jukić N; Kes P; Pasini J
    Acta Clin Croat; 2011 Sep; 50(3):381-4. PubMed ID: 22384774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High power diode laser vaporization of the prostate: preliminary results for benign prostatic hyperplasia.
    Erol A; Cam K; Tekin A; Memik O; Coban S; Ozer Y
    J Urol; 2009 Sep; 182(3):1078-82. PubMed ID: 19616811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of medical therapy on surgery for benign prostatic hyperplasia: a study comparing changes in a decade (1992-2002).
    Vela-Navarrete R; Gonzalez-Enguita C; Garcia-Cardoso JV; Manzarbeitia F; Sarasa-Corral JL; Granizo JJ
    BJU Int; 2005 Nov; 96(7):1045-8. PubMed ID: 16225526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective randomized trial comparing transurethral resection of the prostate and laser therapy in men with chronic urinary retention: The CLasP study.
    Gujral S; Abrams P; Donovan JL; Neal DE; Brookes ST; Chacko KN; Wright MJ; Timoney AG; Peters TJ
    J Urol; 2000 Jul; 164(1):59-64. PubMed ID: 10840425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A comparative study on different doses of cernilton for preventing the clinical progression of benign prostatic hyperplasia].
    Xu J; Qian WQ; Song JD
    Zhonghua Nan Ke Xue; 2008 Jun; 14(6):533-7. PubMed ID: 18649754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of NIH-IV prostatitis on free and free-to-total PSA.
    Stancik I; Lüftenegger W; Klimpfinger M; Müller MM; Hoeltl W
    Eur Urol; 2004 Dec; 46(6):760-4. PubMed ID: 15548444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examination of the relationship between symptoms of prostatitis and histological inflammation: baseline data from the REDUCE chemoprevention trial.
    Nickel JC; Roehrborn CG; O'leary MP; Bostwick DG; Somerville MC; Rittmaster RS
    J Urol; 2007 Sep; 178(3 Pt 1):896-900; discussion 900-1. PubMed ID: 17632164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of chronic prostatitis in radical prostatectomy specimens with up-regulation of bcl-2 in areas of inflammation.
    Gerstenbluth RE; Seftel AD; MacLennan GT; Rao RN; Corty EW; Ferguson K; Resnick MI
    J Urol; 2002 May; 167(5):2267-70. PubMed ID: 11956490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of chronic prostatitis lowers serum prostate specific antigen.
    Bozeman CB; Carver BS; Eastham JA; Venable DD
    J Urol; 2002 Apr; 167(4):1723-6. PubMed ID: 11912396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bipolar plasmakinetic transurethral resection of the prostate vs. transurethral enucleation and resection of the prostate: pre- and postoperative comparisons of parameters used in assessing benign prostatic enlargement.
    Zhang KY; Xing JC; Chen BS; Liu CX; Lau HW; Sim HG; Foo KT
    Singapore Med J; 2011 Oct; 52(10):747-687514. PubMed ID: 22009396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms.
    Emberton M; Lukacs B; Matzkin H; Alcaraz A; Elhilali M; Vallancien G
    J Urol; 2006 Sep; 176(3):1051-6. PubMed ID: 16890690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen deprivation-induced changes in prostate anatomy predict urinary morbidity after permanent interstitial brachytherapy.
    Hinerman-Mulroy A; Merrick GS; Butler WM; Wallner KE; Allen Z; Adamovich E
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1367-82. PubMed ID: 15275722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective, randomized trial comparing conventional transurethral prostate resection with PlasmaKinetic vaporization of the prostate: physiological changes, early complications and long-term followup.
    Hon NH; Brathwaite D; Hussain Z; Ghiblawi S; Brace H; Hayne D; Coppinger SW
    J Urol; 2006 Jul; 176(1):205-9. PubMed ID: 16753403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Change in International Prostate Symptom Score, prostrate-specific antigen and prostate volume in patients with benign prostatic hyperplasia followed longitudinally.
    Tsukamoto T; Masumori N; Rahman M; Crane MM
    Int J Urol; 2007 Apr; 14(4):321-4; discussion 325. PubMed ID: 17470162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification, pharmacologic considerations, and management of prostatitis.
    Schiller DS; Parikh A
    Am J Geriatr Pharmacother; 2011 Feb; 9(1):37-48. PubMed ID: 21459307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.